Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News 3SBIO INC Ord Shs TRSBF

Healthcare Biotechnology
3SBio Inc. is an investment holding company mainly engaged in the the development, production, marketing and sale of pharmaceutical products. The Company’s main products include recombinant human thrombopoietin (rhTPO) products, tumor necrosis factor (TNF)ainhibitor products and recombinant human erythropoietin (rhEPO) products. The products are sold under the name of TPIAO, Yisaipu, EPIAO and... see more

Recent & Breaking News (OTCPK:TRSBF)

    3SBio Unveils 2017 Annual Results: Revenue Soars by 33.5%

    PR Newswire Asia March 26, 2018

    China FDA Approves New Once-Weekly Bydureon(R) to Improve Glycemic Control in Patients with Type-2 Diabetes

    PR Newswire Asia January 4, 2018

    3SBio Accelerates Expansion of its Global Biologics Platform by Acquiring the Canadian Biomanufacturing Business of Therapure

    PR Newswire September 3, 2017

    3SBio Inc. Appoints Dr. Zhenping Zhu as President of Research & Development and Chief Scientific Officer

    PR Newswire Asia January 9, 2017

    3SBio Inc. Announces Completion of Merger

    PR Newswire May 30, 2013

    3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement

    PR Newswire May 24, 2013

    3SBio Inc. Announces Extraordinary General Meeting of Shareholders

    PR Newswire May 2, 2013

    3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012

    PR Newswire May 1, 2013

    3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders

    PR Newswire April 25, 2013

    3SBio Inc. Enters Into Amendment to Merger Agreement For "Going Private" Transaction

    PR Newswire April 24, 2013

    3SBio Inc. Announces Receipt of Amended "Going Private" Proposal at $16.70 Per ADS and Intent to Adjourn Extraordinary General Meeting of Shareholders

    PR Newswire April 22, 2013

    OrbiMed Advisors Announces Institutional Shareholder Services Recommendation that 3SBio Shareholders Vote AGAINST Management Buyout Proposal

    Business Wire April 15, 2013

    Glass Lewis Recommends 3SBio Shareholders Vote against Management Buyout Proposal

    Business Wire April 12, 2013

    3SBio Inc. Announces Extraordinary General Meeting of Shareholders

    PR Newswire March 24, 2013

    3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2012 Results

    PR Newswire March 18, 2013

    3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2012 Results

    PR Newswire March 3, 2013

    Free Research Report on PG&E Corp., 3SBio, Inc., FormFactor, Inc., Cimatron Ltd. and Waters Corp.

    Marketwired February 13, 2013

    3SBio Inc. Enters Into Merger Agreement For "Going Private" Transaction

    PR Newswire February 8, 2013

    Canadian small/micro-cap weekend roundup

    Stockhouse Editorial August 28, 2010

    Junior miner powers higher on HudBay investment

    Sean Mason August 24, 2010